e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Invasive and noninvasive measurements of lung inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adenoviral infection in COPD: assessment with transrenal DNA testing
P. Panagou, G. Papatheodorou, D. Bouros (Athens, Alexandroupolis Thrace, Greece)
Source:
Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Session:
Invasive and noninvasive measurements of lung inflammation
Session type:
E-Communication Session
Number:
4239
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Panagou, G. Papatheodorou, D. Bouros (Athens, Alexandroupolis Thrace, Greece). Adenoviral infection in COPD: assessment with transrenal DNA testing. Eur Respir J 2008; 32: Suppl. 52, 4239
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Viral infection immunodetection reinforce the possible viral participation in the pulmonary fibrosis disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Viral, bacterial or both? Regardless, we need to treat infection in COPD
Source: Eur Respir J 2014; 44: 11-13
Year: 2014
Detection of RSV serotype A-B and adenovirus
via
PCR on samples from patients with COPD: exacerbation vs stable condition
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Development of paediatric asthma following viral infections
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021
Longitudinal profiling of viral infections in COPD patients and their implication to exacerbations
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
High levels of Epstein-Barr virus in COPD
Source: Eur Respir J 2008; 31: 1221-1226
Year: 2008
Rapid detection of major respiratory tract viral infections in acute exacerbation of COPD by highly sensitive multiplex PCR (mPCR)
Source: Annual Congress 2013 –Viral infections
Year: 2013
Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies
Source: International Congress 2019 – Scientific Year in review
Year: 2019
Prevention and treatment of viral infections: CMV and other community respiratory viruses
Source: ERS Course 2016
Year: 2016
Respiratory viral point of care testing (POCT) allows improved infection control and bed management during an influenza outbreak
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
High frequency of viral genomes in pediatric chronic lower respiratory disorders: nasal-wash as a valid substrate for viral detection
Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases
Year: 2009
Viral infection in asthma exacerbations: role of interferon lambda
Source: Eur Respir J 2005; 26: Suppl. 49, 707s
Year: 2005
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007
Prolonged viral RNA shedding in patients with COVID-19 infection
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021
Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Viral infection
Source: Eur Respir Monogr 2017; 77: 76-96
Year: 2017
Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005
Efficacy evaluation, time estimates for method of bronchial valve closure (BVC) in the treatment of patients with double infections of immunodeficiency virus / tuberculosis (HI virus/TB)
Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Year: 2019
Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept